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Background
Many mental health interventions constitute complex
interventions since they are characterised by multiple
components which when given in combination are
thought to improve outcome as well as the components
changing distal clinical outcome indirectly by inducing
change in intermediate process variables (mediation).
Ideally the evaluation of a complex intervention should
be both pragmatic (assess effectiveness) as well as expla-
natory (measure the efficacy of the intervention compo-
nents and separate their direct and indirect effects).
Ordinary least squares (OLS) estimates of parameters of
interest in explanatory analyses will suffer bias despite
random treatment allocation when covariates are endo-
genous. In mental health trials such endogeneity is likely
to arise as the result of non-compliance with rando-
mised treatments, hidden confounding or measurement
error in the treatment components received or process
variables.
In this talk I discuss ways of designing a complex
intervention trial so that all causal parameters of interest
can be estimated consistently using instrumental vari-
able (IV) methods.
Methods
Pearl’s graphical checks of identifiability are applied to
establish the most general causal model for mental
health complex intervention trials under which para-
meters of interest remain identified.
Having determined this model, experimental actions
including the generation of relevant IVs, that can ensure
model assumptions hold, are reviewed.
Monte Carlo simulations are carried out to compare
the performance of naïve OLS estimators with that of
IV estimators.
Results
Allowing for non-compliance with randomised treat-
ment offers, hidden confounding or measurement errors
requires independent randomisation of constituent treat-
ment components and the availability of further instru-
ments for hypothesised process variables. A number of
avenues for generating the latter exist.
Simulations confirm that the biases suffered by OLS
estimators are corrected by IV methods. The variance
inflation of IV treatment component effect estimators is
acceptable in standard sized mental health trials. How-
ever, instruments for process variables may be less
strong raising the possibility that the variance inflation
of mediation effect estimators renders them impractical
for use.
Conclusions
Investigators planning to carry out explanatory analyses
of complex interventions should consider the generation
of relevant IVs at the design stage.
The unbiased estimation of (total) effects of the treat-
ment components actually received (efficacy) is feasible
under non-compliance or treatment misclassification.
The generation of strong IVs for process variables may
be more problematic. In mental health research media-
tion analyses allowing for hidden confounding and mea-
surement error may only be feasible for large trials or
after combining trials.
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